Extensive studies have suggested that impaired oxidative stress is associated with the occurrence and progression of MASLD/MASH through the overproduction of reactive oxygen species (ROS) to mediate lipid metabolism, insulin signaling, and innate immune signaling pathways (33–35). Here, INS is linked to metabolic dysfunction-associated steatohepatitis.